Recent Finacing
Recent Raise
SalioGen Therapeutics develops EDIT, a non-viral gene platform using mammal-derived saliogase and LNP delivery to integrate DNA cargos into defined genomic loci for genetic medicines, cell therapy, and biologics manufacturing.
